These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 26953190)

  • 1. Inhibitors of Ribosome Rescue Arrest Growth of Francisella tularensis at All Stages of Intracellular Replication.
    Goralski TD; Dewan KK; Alumasa JN; Avanzato V; Place DE; Markley RL; Katkere B; Rabadi SM; Bakshi CS; Keiler KC; Kirimanjeswara GS
    Antimicrob Agents Chemother; 2016 Jun; 60(6):3276-82. PubMed ID: 26953190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A New Mechanism for Ribosome Rescue Can Recruit RF1 or RF2 to Nonstop Ribosomes.
    Goralski TDP; Kirimanjeswara GS; Keiler KC
    mBio; 2018 Dec; 9(6):. PubMed ID: 30563899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. KKL-35 Exhibits Potent Antibiotic Activity against Legionella Species Independently of
    Brunel R; Descours G; Durieux I; Doublet P; Jarraud S; Charpentier X
    Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29158279
    [No Abstract]   [Full Text] [Related]  

  • 4. Novel engineered cationic antimicrobial peptides display broad-spectrum activity against Francisella tularensis, Yersinia pestis and Burkholderia pseudomallei.
    Abdelbaqi S; Deslouches B; Steckbeck J; Montelaro R; Reed DS
    J Med Microbiol; 2016 Feb; 65(2):188-194. PubMed ID: 26673248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Control of Francisella tularensis Intracellular Growth by Pulmonary Epithelial Cells.
    Maggio S; Takeda K; Stark F; Meierovics AI; Yabe I; Cowley SC
    PLoS One; 2015; 10(9):e0138565. PubMed ID: 26379269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toll-like receptor 2-mediated signaling requirements for Francisella tularensis live vaccine strain infection of murine macrophages.
    Cole LE; Shirey KA; Barry E; Santiago A; Rallabhandi P; Elkins KL; Puche AC; Michalek SM; Vogel SN
    Infect Immun; 2007 Aug; 75(8):4127-37. PubMed ID: 17517865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Ribosomal Protein Homolog Governs Gene Expression and Virulence in a Bacterial Pathogen.
    Trautmann HS; Ramsey KM
    J Bacteriol; 2022 Oct; 204(10):e0026822. PubMed ID: 36121290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benzimidazole-based antibacterial agents against Francisella tularensis.
    Kumar K; Awasthi D; Lee SY; Cummings JE; Knudson SE; Slayden RA; Ojima I
    Bioorg Med Chem; 2013 Jun; 21(11):3318-26. PubMed ID: 23623254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of resazurin as a novel antimicrobial agent against Francisella tularensis.
    Schmitt DM; O'Dee DM; Cowan BN; Birch JW; Mazzella LK; Nau GJ; Horzempa J
    Front Cell Infect Microbiol; 2013; 3():93. PubMed ID: 24367766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of Francisella tularensis LVS infection of macrophages results in a reduced inflammatory response: evaluation of a therapeutic strategy for intracellular bacteria.
    D'Elia R; Jenner DC; Laws TR; Stokes MG; Jackson MC; Essex-Lopresti AE; Atkins HS
    FEMS Immunol Med Microbiol; 2011 Aug; 62(3):348-61. PubMed ID: 21569124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FmvB: A Francisella tularensis Magnesium-Responsive Outer Membrane Protein that Plays a Role in Virulence.
    Wu X; Ren G; Gunning WT; Weaver DA; Kalinoski AL; Khuder SA; Huntley JF
    PLoS One; 2016; 11(8):e0160977. PubMed ID: 27513341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outer membrane vesicle-associated lipase FtlA enhances cellular invasion and virulence in Francisella tularensis LVS.
    Chen F; Cui G; Wang S; Nair MKM; He L; Qi X; Han X; Zhang H; Zhang JR; Su J
    Emerg Microbes Infect; 2017 Jul; 6(7):e66. PubMed ID: 28745311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benzoxazoles, Phthalazinones, and Arylurea-Based Compounds with IMP Dehydrogenase-Independent Antibacterial Activity against Francisella tularensis.
    Gorla SK; Zhang Y; Rabideau MM; Qin A; Chacko S; House AL; Johnson CR; Mandapati K; Bernstein HM; McKenney ES; Boshoff H; Zhang M; Glomski IJ; Goldberg JB; Cuny GD; Mann BJ; Hedstrom L
    Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28739786
    [No Abstract]   [Full Text] [Related]  

  • 14. Construction and characterization of an attenuated purine auxotroph in a Francisella tularensis live vaccine strain.
    Pechous R; Celli J; Penoske R; Hayes SF; Frank DW; Zahrt TC
    Infect Immun; 2006 Aug; 74(8):4452-61. PubMed ID: 16861631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Susceptibility of immunodeficient mice to aerosol and systemic infection with virulent strains of Francisella tularensis.
    Chen W; KuoLee R; Shen H; Conlan JW
    Microb Pathog; 2004 Jun; 36(6):311-8. PubMed ID: 15120157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mouse model of oral infection with virulent type A Francisella tularensis.
    KuoLee R; Zhao X; Austin J; Harris G; Conlan JW; Chen W
    Infect Immun; 2007 Apr; 75(4):1651-60. PubMed ID: 17242058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sensitivity of Francisella tularensis to ultrapure water and deoxycholate: implications for bacterial intracellular growth assay in macrophages.
    Chalabaev S; Anderson CA; Onderdonk AB; Kasper DL
    J Microbiol Methods; 2011 Jun; 85(3):230-2. PubMed ID: 21420447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gallium Potentiates the Antibacterial Effect of Gentamicin against Francisella tularensis.
    Lindgren H; Sjöstedt A
    Antimicrob Agents Chemother; 2016 Jan; 60(1):288-95. PubMed ID: 26503658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ribosome heterogeneity results in leader sequence-mediated regulation of protein synthesis in
    Trautmann HS; Schmidt SS; Gregory ST; Ramsey KM
    J Bacteriol; 2023 Sep; 205(9):e0014023. PubMed ID: 37676009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Francisella tularensis Live Vaccine Strain deficient in capB and overexpressing the fusion protein of IglA, IglB, and IglC from the bfr promoter induces improved protection against F. tularensis respiratory challenge.
    Jia Q; Bowen R; Lee BY; Dillon BJ; Masleša-Galić S; Horwitz MA
    Vaccine; 2016 Sep; 34(41):4969-4978. PubMed ID: 27577555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.